| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.2M | -73.6% |
| R&D Expense | $89.3M | +48.4% |
| SG&A Expense | $28.7M | -2.6% |
| Operating Income | -$116.6M | -52.5% |
| Pre-tax Income | -$113.9M | -56.6% |
| Income Tax | $55K | +685.7% |
| Net Income | -$113.9M | -56.6% |
| EPS (Basic) | -$1.17 | -53.9% |
| EPS (Diluted) | -$1.17 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $32.5M | -77.0% |
| Current Assets | $44.4M | -72.1% |
| Total Assets | $65.7M | -64.1% |
| Current Liabilities | $31.1M | -16.6% |
| Total Liabilities | $38.3M | -10.6% |
| Stockholders' Equity | $27.4M | -80.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$104.5M | -31.2% |
| Capital Expenditures | $2.3M | +245.3% |
| Investing Cash Flow | -$757K | +6.3% |
| Financing Cash Flow | $587K | -91.3% |
| Free Cash Flow | -$106.8M | -33.0% |
| -53.9% |